LeonaBio (LONA) Debt Ratio (2022 - 2024)

LeonaBio's (LONA) quarterly Debt Ratio came in at 0.12 in Q3 2024, up 114.15% year-on-year from 0.05 in Q4 2023, and up 28.99% on a QoQ basis from 0.09 in Q2 2024.

LeonaBio (LONA) Debt Ratio (2022 - 2024) Analysis & Trends

LeonaBio (LONA) has 3 years of Debt Ratio data on file, last reported at 0.12 in Q3 2024.

  • On a quarterly basis, Debt Ratio rose 114.15% year-over-year to 0.12 in Q3 2024; TTM through Sep 2024 was 0.12, a 114.15% increase from a year earlier, with the FY2023 full-year figure at 0.06, up 61.1% from the prior year.
  • Debt Ratio for Q3 2024 stood at 0.12, up from 0.09 in the prior quarter.
  • Over the last five years, Debt Ratio for LONA reached as high as 0.12 in Q3 2024 and fell as low as 0.04 in Q4 2022.
  • Historically, Debt Ratio has averaged 0.07 across 3 years, with a median of 0.06 in 2023.
  • Across the five-year window, Debt Ratio soared 61.1% in 2023 and surged 114.15% in 2024, its largest moves.
  • Year by year, Debt Ratio stood at 0.04 in 2022, then surged by 61.1% to 0.06 in 2023, then surged by 85.8% to 0.12 in 2024.
  • Per Business Quant data, the three most recent Debt Ratio figures were 0.12 in Q3 2024, 0.09 in Q2 2024, and 0.07 in Q1 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - 1.41
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 0.11
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 0.05
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - -
10 LeonaBio 138.33 Mn 70.65 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2024 0.12
Jun 30, 2024 0.09
Mar 31, 2024 0.07
Dec 31, 2023 0.06
Sep 30, 2023 0.05
Jun 30, 2023 0.05
Mar 31, 2023 0.04
Dec 31, 2022 0.04